The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 16,301–16,400 of 31,469
Venojärvi, M., Korkmaz, A., Aunola, S., Hällsten, K., Virtanen, K. A., Marniemi, J., Halonen, J.-P., Hänninen, O., Nuutila, P., & Atalay, M. (2014) · BioMed Research International · doi:10.1155/2014/386351 · Cited by 17
Mavrogiannaki, A. N., Karamanos, B. G., Manesis, E. K., et al. (2009) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2009.01077.x · Cited by 18
Venkataraman, V., Amutha, A., Anbalagan, V. P., Deepa, M., Anjana, R. M., Ranjit Unnikrishnan, I., Vamsi, M., & Mohan, V. (2012) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2012.06.002 · Cited by 18
Rhee, S. Y., Kim, J. Y., Chon, S., Hwang, Y., Jeong, I., Oh, S., Ahn, K. J., Chung, H. Y., Woo, J., Kim, S. W., et al. (2010) · Korean Diabetes Journal · doi:10.4093/kdj.2010.34.3.157 · Cited by 18
Nondiabetic Ketoacidosis Caused by Severe Hyperthyroidism
Wood, E. T., & Kinlaw, W. B. (2004) · Thyroid · doi:10.1089/1050725041692945 · Cited by 18
Coppini, L. Z., Bertevello, P. L., Gama-Rodrigues, J. J., & Waitzberg, D. L. (2006) · Obesity Surgery · doi:10.1381/096089206778870030 · Cited by 18
Auinger, A., Helwig, U., Rubin, D. C., et al. (2010) · Journal of Nutrition · doi:10.3945/jn.109.118034 · Cited by 18
Shargorodsky, M., Hass, E. E., Boaz, M., Gavish, D., & Zimlichman, R. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.12.036 · Cited by 20
Millán, J. L. S., Álvarez‐Blasco, F., Luque‐Ramírez, M., Botella-Carretero, J. I., & Escobar-Morreale, H. F. (2006) · Human Reproduction · doi:10.1093/humrep/del300 · Cited by 18
Mackenzie, J., Koekemoer, T., Roux, S., van de Venter, M., & Dealtry, G. (2012) · Phytotherapy Research · doi:10.1002/ptr.4653 · Cited by 18
Wang, Y., Qin, M.-Z., Liu, Q., Liu, Q., & Chang, Z.-W. (2010) · Journal of International Medical Research · doi:10.1177/147323001003800342 · Cited by 18
Heiskanen, N., Saarelainen, H., Kärkkäinen, H., Valtonen, P., Lyyra‐Laitinen, T., Laitinen, T. P., Vanninen, E. J., & Heinonen, S. T. (2009) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2008.12.006 · Cited by 18
Sex-dimorphism in Cardiac Nutrigenomics: effect of Trans fat and/or Monosodium Glutamate consumption
Collison, K. S., Zaidi, M. Z., Maqbool, Z. M., Saleh, S. M., Inglis, A. L., Makhoul, N. J., Bakheet, R., Shoukri, M. M., & Al-Mohanna, F. A. (2011) · BMC Genomics · doi:10.1186/1471-2164-12-555 · Cited by 18
Yokoyama, H., Inoue, T., & Node, K. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.09.049 · Cited by 18
Collison, K. S., Makhoul, N. J., Zaidi, M. Z., Inglis, A. L., Andres, B. L., Ubungen, R., Saleh, S. M., & Al-Mohanna, F. A. (2013) · Nutrition & Metabolism · doi:10.1186/1743-7075-10-44 · Cited by 18
Alizadeh, M., Gharaaghaji, R., & Gargari, B. P. (2014) · PubMed Central · Cited by 20
Park, J. H., Oh, S. W., Ahn, S. Y., et al. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.12.006 · Cited by 18
Short day-length increases sucrose consumption and adiposity in rats fed a high-fat diet
Sinitskaya, N., Schuster, C., Lemaître, B. J., Gourmelen, S., Pévet, P., & Challet, É. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.07.003 · Cited by 18
Bellou, E., Maraki, M. I., Magkos, F., Botonaki, H., Panagiotakos, D. B., Kavouras, S. A., & Sidossis, L. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060251 · Cited by 18
Fatores associados à resistência à insulina em populações rurais
Mendes, L. L., Gazzinelli, A., & Velásquez-Meléndez, G. (2009) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302009000300006 · Cited by 18
Rojo‐Martínez, G., Soriguer, F., Colomo, N., CALLE, A. L., Goday, A., Bordiú, E., Delgado, E., Torre, E. L. M., Ortega, E., Urrutia, I., et al. (2012) · European Journal of Clinical Investigation · doi:10.1111/eci.12002 · Cited by 19
Wierzbicki, A. S., Pendleton, S., McMahon, Z., et al. (2011) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2011.02683.x · Cited by 18
Spectrum of insulin sensitivity in the Korean population
Ryu, S., Sung, K., Chang, Y., Lee, W., & Rhee, E. (2005) · Metabolism · doi:10.1016/j.metabol.2005.06.014 · Cited by 18
Overexpression of STAMP 2 suppresses atherosclerosis and stabilizes plaques in diabetic mice
Wang, J., Han, L., Wang, Z., Ding, W., Shang, Y., Tang, M., Li, W., Zhang, Y., Zhang, W., & Zhong, M. (2014) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12222 · Cited by 18
Scheja, L., Heese, B., & Seedorf, K. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.02.137 · Cited by 18
Meral, C., Çekmez, F., Vurucu, S., et al. (2011) · European Cytokine Network · doi:10.1684/ecn.2011.0284 · Cited by 18
Kramer, C. K., Zinman, B., Choi, H., & Retnakaran, R. R. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1947 · Cited by 18
Oyster extracts attenuate pathological changes in non-alcoholic steatohepatitis (NASH) mouse model
Watanabe, M., Fuda, H., Okabe, H., Joko, S., Miura, Y., Hui, S., Yimin, Hamaoka, N., Miki, E., & Chiba, H. (2015) · Journal of Functional Foods · doi:10.1016/j.jff.2015.11.029 · Cited by 18
Nagaraj, N., Matthews, K. A., Shields, K. J., et al. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.10.095 · Cited by 18
Matsuba, R., Sakai, K., Imamura, M., Tanaka, Y., Iwata, M., Hirose, H., Kaku, K., Maegawa, H., Watada, H., Tobe, K., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126363 · Cited by 18
Formisano, A., Bammann, K., Fraterman, A., Hadjigeorgiou, C., Herrmann, D., Iacoviello, L., Mårild, S., Moreno, L. A., Nagy, P., den Bussche, K. V., et al. (2016) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2016.02.012 · Cited by 18
Martin, C. L., Siega‐Riz, A. M., Sotres‐Alvarez, D., Robinson, W. R., Daniels, J. L., Perrin, E. M., & Stuebe, A. M. (2016) · Paediatric and Perinatal Epidemiology · doi:10.1111/ppe.12279 · Cited by 18
Larrad, M. T. M., Anchuelo, A. C., Fernández, C., Barba, M. P., Redondo, Y. L., Serrano‐Ríos, M., & Segovia Insulin Resistance Study Group (SIRSG) (2016) · PLoS ONE · doi:10.1371/journal.pone.0153976 · Cited by 18
Triantafyllou, Α., Anyfanti, P., Triantafyllou, G. A., et al. (2016) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2016.04.007 · Cited by 18
Metabolic Profiles of Obesity in American Indians: The Strong Heart Family Study
Zhao, Q., Zhu, Y., Best, L. G., Umans, J. G., Uppal, K., Tran, V. T., Jones, D. P., Lee, E. T., Howard, B. V., & Zhao, J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0159548 · Cited by 18
Suárez‐Ortegón, M. F., McLachlan, S., Wild, S. H., Fernández‐Real, J. M., Hayward, C., & Polašek, O. (2016) · British Journal Of Nutrition · doi:10.1017/s0007114516002968 · Cited by 18
Galarza, E. J., Medina-Urrutia, A. X., Posadas‐Sánchez, R., Posadas‐Romero, C., Cardoso-Saldaña, G. C., Vargas‐Alarcón, G., Caracas-Portilla, N., González-Salazar, C., Torres‐Tamayo, M., & Juárez-Rojas, J. G. (2016) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-016-0189-6 · Cited by 18
Exercise training ameliorates glucosamine-induced insulin resistance in ovariectomized rats
Chen, C., Huang, T., Cheng, T., Chang, C.-F., Wang, C., Wu, M., & Kang, L. (2016) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000811 · Cited by 17
Bonadonna, R. C., Blonde, L., Antsiferov, M. B., Berria, R., Gourdy, P., Hatunic, M., Mohan, V., & Horowitz, M. (2017) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2897 · Cited by 17
Erol, O. Ö., Özel, M. K., Elli̇dağ, H. Y., Toptaş, T., Uysal, A., & Yılmaz, N. (2017) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2017.1286464 · Cited by 18
Ha, A. W., & Kim, W. K. (2017) · Nutrition Research and Practice · doi:10.4162/nrp.2017.11.3.206 · Cited by 18
Metformin prevents vascular prostanoid release alterations induced by a high‐fat diet in rats
Lee, H. J., Cantú, S. M., Donoso, A. S., Choi, M. R., Peredo, H. A., & Puyó, A. M. (2017) · Autonomic and Autacoid Pharmacology · doi:10.1111/aap.12057 · Cited by 18
Association of insulin resistance and autonomic tone in patients with pregnancy-induced hypertension
Guo, J., Liu, G., & Guo, G. (2017) · Clinical and Experimental Hypertension · doi:10.1080/10641963.2017.1403619 · Cited by 18
Agostinis-Sobrinho, C., Ruiz, J., Moreira, C., Abreu, S., Lopes, L., Oliveira-Santos, J., Mota, J., & Santos, R. (2017) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2017.09.012 · Cited by 15
Meal‐related oscillations in the serum serotonin levels in healthy young men
Kwon, O., Yu, J. H., Jeong, E., Yoo, H. J., & Kim, M. (2018) · Clinical Endocrinology · doi:10.1111/cen.13545 · Cited by 18
Liang, S., Xue, J., & Li, G. (2018) · Lipids in Health and Disease · doi:10.1186/s12944-018-0721-9 · Cited by 18
Tsuboi, A., Minato, S., Yano, M., Takeuchi, M., Kitaoka, K., Kurata, M., Yoshino, G., Wu, B., Kazumi, T., & Fukuo, K. (2018) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2018-000508 · Cited by 18
Beasley, J. M., Yi, S. S., Ahn, J., et al. (2018) · Journal of Immigrant and Minority Health · doi:10.1007/s10903-018-0800-z · Cited by 18
Bergia, R. E., Kim, J. E., & Campbell, W. W. (2018) · International Journal of Endocrinology · doi:10.1155/2018/2751250 · Cited by 19
Leutner, M., Klimek, P., Göbl, C. S., Bozkurt, L., Harreiter, J., Husslein, P. W., Eppel, W., Baumgartner-Parzer, S. M., Pacini, G., Stefan Thurner, A., et al. (2018) · Metabolism · doi:10.1016/j.metabol.2018.10.006 · Cited by 18
Demir, E. Y., Harmankaya, N. Ö., Utku, İ. K., Açıksarı, G., Uygun, T., Ozkan, H., & Demir, B. (2019) · Biomolecules · doi:10.3390/biom9030097 · Cited by 18
Lifetime marijuana use in relation to insulin resistance in lean, overweight, and obese US adults
Ngueta, G., & Ndjaboué, R. (2019) · Journal of Diabetes · doi:10.1111/1753-0407.12958 · Cited by 19
An, J., Yoon, S. R., Lee, J. H., Kim, H.-Y., & Kim, O. Y. (2019) · Clinical Nutrition Research · doi:10.7762/cnr.2019.8.3.171 · Cited by 18
Thani, M. A., Sadoun, E., Sofroniou, A., Jayyousi, A., Baagar, K. A. M., Al-Hamaq, A. O. A. A., Vinodson, B., Akram, H., Bhatti, Z. S., Nasser, H. S., et al. (2019) · BMC Nutrition · doi:10.1186/s40795-019-0311-x · Cited by 18
de Luis, D. A., Izaola, O., Primo, D., & Aller, R. (2020) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2020.107534 · Cited by 21
NADPH Oxidase 2 Mediates Myocardial Oxygen Wasting in Obesity
Hafstad, A. D., Hansen, S. S., Lund, J., Santos, C. X. C., Boardman, N. T., Shah, A. M., & Aasum, E. (2020) · Antioxidants · doi:10.3390/antiox9020171 · Cited by 18
Carlson, Z., Hafner, H., Mulcahy, M. C., Bullock, K., Zhu, A., Bridges, D., Bernal-Mizrachi, E., & Gregg, B. (2020) · American Journal of Physiology. Endocrinology and Metabolism · doi:10.1152/ajpendo.00473.2019 · Cited by 16
Role of adiponectin and leptin in patients with alopecia areata with scalp hair loss
Serarslan, G., Özcan, O., Okyay, E., Ünlü, B., & Karadağ, M. (2020) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-020-02410-4 · Cited by 18
Karras, S. Ν., Annweiler, C., Kiortsis, D., Koutelidakis, I. M., & Kotsa, K. (2020) · Nutrients · doi:10.3390/nu12113522 · Cited by 19
de Giorgis, T., Marcovecchio, M. L., Giannini, C., et al. (2015) · Journal of Endocrinological Investigation · doi:10.1007/s40618-015-0351-2 · Cited by 18
Anti-diabetic Effect and Mechanism of Korean Red Ginseng in C57BL/KsJ db/db Mice
Yuan, H. D. (2008) · Journal of Ginseng Research · doi:10.5142/jgr.2008.32.3.187 · Cited by 18
Dumont, M., Mauriège, P., Bergeron, J., Després, J., & Prud’homme, D. (2001) · International Journal of Obesity · doi:10.1038/sj.ijo.0801665 · Cited by 18
Lo, J., You, S. M., Wei, J., Hron, B. M., & Grinspoon, S. K. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03603.x · Cited by 18
Halkes, C. J. M., van Wijk, J. P. H., Ribalta, J., Masana, L., & Cabezas, M. C. (2003) · Journal of Internal Medicine · doi:10.1046/j.0954-6820.2003.01252.x · Cited by 18
Insulin Resistance Contributes to Obesity-Related Proteinuria
Matsumoto, H., Nakao, T., OKADA, T., Nagaoka, Y., Iwasawa, H., Tomaru, R., & Wada, T. (2005) · Internal Medicine · doi:10.2169/internalmedicine.44.548 · Cited by 17
Leptin as a Marker of Body Fat and Hyperinsulinemia in College Students
Kempf, A. M., Strother, M. L., Li, C., et al. (2006) · Journal of American College Health · doi:10.3200/jach.55.3.175-180 · Cited by 18
Adiponectin is involved in the protective effect of DHEA against metabolic risk in aged rats
de Heredia, F. P., Sánchez, J., Priego, T., Nicolás, F., Portillo, M. P., Palou, A., Zamora, S., & Garaulet, M. (2008) · Steroids · doi:10.1016/j.steroids.2008.04.011 · Cited by 18
Improvement of Glucose Metabolism After a Pancreatoduodenectomy
Ohtsuka, T., Kitahara, K., Kohya, N., Miyoshi, A., & Miyazaki, K. (2009) · Pancreas · doi:10.1097/mpa.0b013e3181a7c916 · Cited by 18
Hung, Y., Lin, S., Pei, D., Kuo, S., Hsieh, C., He, C., Lee, C., Fan, S. C., & Sheu, W. H. (2006) · Metabolism · doi:10.1016/j.metabol.2005.10.004 · Cited by 18
Plasma obestatin levels in men with chronic atrophic gastritis
Gao, X., Kuang, H., Liu, X.-M., et al. (2008) · Peptides · doi:10.1016/j.peptides.2008.05.027 · Cited by 18
Méndez‐Sánchez, N., Chávez-Tapia, N. C., Medina‐Santillán, R., Villa, A. R., Sánchez-Lara, K., Ponciano‐Rodríguez, G., Ramos, M. H., & Uribe, M. (2006) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-9093-5 · Cited by 18
Ikeda, T., Gomi, T., Shibuya, Y., Shinozaki, S., Suzuki, Y., & MATSUDA, N. (2007) · Hypertension Research · doi:10.1291/hypres.30.1097 · Cited by 18
Evans, K., Burdge, G. C., Wootton, S. A., Collins, J. M., Clark, M. L., Tan, G. D., Karpe, F., & Frayn, K. N. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.03.009 · Cited by 18
Pancreatic β‐cell function and fetal growth in gestational impaired glucose tolerance
Miyakoshi, K., Tanaka, M., Saisho, Y., Shimada, A., Minegishi, K., Kim, S. H., ASAI, S., Itoh, H., & Yoshimura, Y. (2010) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016349.2010.487091 · Cited by 18
de Luis, D. A., Sagrado, M. G., Aller, R., Izaola, O., Conde, R., & Romero, E. (2009) · Obesity Surgery · doi:10.1007/s11695-009-9859-x · Cited by 18
Insulin Resistance Is Common in Patients with Predominantly Genotype 3 Chronic Hepatitis C
Duseja, A. K., Dhiman, R. K., Chawla, Y. K., et al. (2009) · Digestive Diseases and Sciences · doi:10.1007/s10620-009-0844-y · Cited by 18
Sheu, W. H., Chen, Y. I., Yu, C.-Y., Guo, X., Lee, T.-C., Lee, W., Chen, Y., & Rotter, J. I. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2007.04.013 · Cited by 18
Watts, G. F., Chan, D. C., Barrett, P. H. R., Martins, I. J., & Redgrave, T. G. (2001) · Clinical Science · doi:10.1042/cs1010683 · Cited by 18
Matsuda, Y., Tanioka, T., Yoshioka, T., Nagano, T., Hiroi, T., YOSHIKAWA, K., Okabe, K.-I., Nagamine, I., & Takasaka, Y. (2005) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2005.01370.x · Cited by 18
Combined chelation therapy improves glucose metabolism in patients with β‐thalassaemia major
Christoforidis, A., Perifanis, V., & Athanassiou‐Metaxa, M. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06296.x · Cited by 18
Mourad, A. A. E., Heeba, G. H., Taye, A., & El‐Moselhy, M. A. (2012) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2012.01048.x · Cited by 18
Acute Effect of Fatmax Exercise on the Metabolism in Overweight and Nonoverweight Girls
Zakrzewski-Fruer, J. K., & Tolfrey, K. (2012) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e31825804cf · Cited by 18
Koiou, E., Dinas, K. D., Τζιόμαλος, Κ., Toulis, K. A., Kandaraki, E., Kalaitzakis, E., Katsikis, I., & Panidis, D. (2011) · Obesity Facts · doi:10.1159/000327935 · Cited by 18
Metabolic dysfunction in anorexia nervosa
Heilbronn, L. K., Milner, K., Kriketos, A. D., et al. (2007) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2007.03.003 · Cited by 18
Køster, B., Fenger, M., Poulsen, P., et al. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01700.x · Cited by 18
Ryan, P., Resino, S., Miralles, P., et al. (2010) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181e5b1f0 · Cited by 18
Yoo, T. W., Sung, K., Kim, Y. C., Hwang, S. T., Oh, S. Y., Shin, H. S., Kim, B. J., Kim, B. S., Kang, J. H., Lee, M. H., et al. (2004) · Korean Circulation Journal · doi:10.4070/kcj.2004.34.9.874 · Cited by 18
Vimaleswaran, K. S., Radha, V., Deepa, R., & Mohan, V. (2007) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2006.0032 · Cited by 18
Can the metabolic syndrome identify children with insulin resistance?
Hirschler, V., Calcagno, M. L., Aranda, C., Maccallini, G., & Jadzinsky, M. N. (2007) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2007.00282.x · Cited by 18
Epidemiology of the metabolic syndrome and the RISC study
Balkau, B. (2005) · European Heart Journal Supplements · doi:10.1093/eurheartj/sui022 · Cited by 18
Naderali, E. K., Fatani, S. H., & Williams, G. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.07.029 · Cited by 18
Altered insulin sensitivity, insulin secretion and lipid profile in non-diabetic prostate carcinoma
Nandeesha, H., Koner, B. C., & Dorairajan, L. N. (2008) · Acta Physiologica Hungarica · doi:10.1556/aphysiol.95.2008.1.7 · Cited by 18
Insulin resistance in polycystic ovary syndrome: hyperandrogenemia versus normoandrogenemia
Yıldız, B. O., & Gedik, O. (2001) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/s0301-2115(01)00458-4 · Cited by 18
Matsumoto, K., Sakamaki, H., Izumino, K., Yano, M., Ueki, Y., Miyake, S., & Tominaga, Y. (2000) · Metabolism · doi:10.1053/meta.2000.8623 · Cited by 17
Shiba, T. (2003) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(03)00169-4 · Cited by 18
Wasada, T., Kawahara, R., & Iwamoto, Y. (2000) · Diabetes Care · doi:10.2337/diacare.23.7.1039 · Cited by 17
Hyperinsulinemic hypoalphalipoproteinemia as a new indicator for coronary heart disease
Saku, K., Zhang, B., Shirai, K., Jimi, S., Yoshinaga, K., & Arakawa, K. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00372-1 · Cited by 18
PPARγ2 Pro12Ala Polymorphism and Insulin Resistance in Japanese Hypertensive Patients
YAMAMOTO, J., Kageyama, S., Nemoto, M., et al. (2002) · Hypertension Research · doi:10.1291/hypres.25.25 · Cited by 18
Tumor necrosis factor-β gene Nco I polymorphism decreases insulin resistance in Japanese men
Hayakawa, T., Nagai, Y., Taniguchi, M., Yamashita, H., Takamura, T., Abe, T., Nomura, G., & KOBAYASHI, K. P. (2000) · Metabolism · doi:10.1053/meta.2000.17710 · Cited by 18
Fasting Plasma Insulin Modulates Lipid Levels and Particle Sizes in 2‐ to 3‐Year‐Old Children
Shea, S. A., Aymong, E. D., ZYBERT, P. A., Berglund, L., Shamoon, H., Deckelbaum, R. J., & Basch, C. E. (2003) · Obesity Research · doi:10.1038/oby.2003.101 · Cited by 18
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
